Literature DB >> 25937780

Activation of Toll-like receptors signaling in non-small cell lung cancer cell line induced by tumor-associated macrophages.

Xing Ke1, Meng Wu1, Jianfang Lou1, Shuping Zhang1, Peijun Huang1, Ruihong Sun1, Lei Huang1, Erfu Xie1, Fang Wang1, Bing Gu1.   

Abstract

BACKGROUND: Inflammation is often linked with the progress and poor outcome of lung cancer. The understanding of the relationship between tumor-associated macrophages (TAMs) and lung cancer cells involves in the underlying mechanism of inflammatory cytokine production. Toll-like receptors (TLRs) are engaged in promoting the production of pro-inflammatory cytokines and play an important role in tumor immunology.
METHODS: To investigate the mechanisms by which TAMs influence the production of pro-inflammatory cytokines in lung cancer cells, we established an in vitro coculture system using TAMs and human non-small cell lung cancer (NSCLC) cell line SPC-A1. Levels of interleukin (IL)-1β, IL-6 and IL-8 in SPC-A1 were evaluated by RT-PCR and cytometric bead array assay after being cocultured with TAMs. Expression changes of TLRs and TLRs signaling pathway proteins in SPC-A1 were further confirmed by RT-PCR and western blot. The level changes of IL-1β, IL-6 and IL-8 in SPC-A1 were also detected after the stimulation of TLRs agonists.
RESULTS: We found that the phenotype markers of TAMs were highly expressed after stimulating human monocyte cell line THP-1 by phorbol-12-myristate-13-acetate (PMA). Higher mRNA and supernate secretion levels of IL-1β, IL-6 and IL-8 were detected in SPC-A1 after being cocultured with TAMs. We also found that TLR1, TLR6 and TLR7 were up-regulated in SPC-A1 in the coculture system with TAMs. Meanwhile, TLRs signaling pathway proteins were also significantly activated. Moreover, pre-treatment with agonist ligands for TLR1, TLR6 and TLR7 could dramatically promote inductions of IL-1β, IL-6 and IL-8.
CONCLUSIONS: These findings demonstrated that TAMs may enhance IL-1β, IL-6 and IL-8 expressions via TLRs signaling pathway. We conclude that TAMs contribute to maintain the inflammation microenvironment and ultimately promote the development and progression of lung cancer.

Entities:  

Keywords:  Toll-like receptors (TLRs); Tumor-associated macrophages (TAMs); non-small cell lung cancer (NSCLC); pro-inflammatory cytokines

Year:  2015        PMID: 25937780      PMCID: PMC4409966          DOI: 10.3978/j.issn.1000-9604.2015.03.07

Source DB:  PubMed          Journal:  Chin J Cancer Res        ISSN: 1000-9604            Impact factor:   5.087


  35 in total

1.  IL-1β-mediated repression of microRNA-101 is crucial for inflammation-promoted lung tumorigenesis.

Authors:  Lin Wang; Ling-Fei Zhang; Jing Wu; Shu-Jun Xu; Yang-Yang Xu; Dangsheng Li; Jia-Tao Lou; Mo-Fang Liu
Journal:  Cancer Res       Date:  2014-06-23       Impact factor: 12.701

2.  Interaction of coagulation factors and tumor-associated macrophages mediates migration and invasion of gastric cancer.

Authors:  Ying-Yu Ma; Xu-Jun He; Hui-Ju Wang; Ying-Jie Xia; Sheng-Li Wang; Zai-Yuan Ye; Hou-Quan Tao
Journal:  Cancer Sci       Date:  2010-12-07       Impact factor: 6.716

Review 3.  The role of inflammation in lung cancer.

Authors:  Mónica Gomes; Ana Luísa Teixeira; Ana Coelho; António Araújo; Rui Medeiros
Journal:  Adv Exp Med Biol       Date:  2014       Impact factor: 2.622

4.  Peli1 facilitates TRIF-dependent Toll-like receptor signaling and proinflammatory cytokine production.

Authors:  Mikyoung Chang; Wei Jin; Shao-Cong Sun
Journal:  Nat Immunol       Date:  2009-09-06       Impact factor: 25.606

5.  M2-polarized macrophages contribute to the decreased sensitivity of EGFR-TKIs treatment in patients with advanced lung adenocarcinoma.

Authors:  Bicheng Zhang; Yafei Zhang; Jie Zhao; Zhigang Wang; Tingting Wu; Wuling Ou; Jun Wang; Bo Yang; Yong Zhao; Zhiguo Rao; Jianfei Gao
Journal:  Med Oncol       Date:  2014-07-18       Impact factor: 3.064

Review 6.  Epidermal growth factor receptors and cyclooxygenase-2 in the pathogenesis of non-small cell lung cancer: potential targets for chemoprevention and systemic therapy.

Authors:  C M Richardson; R A Sharma; G Cox; Kenneth J O'Byrne
Journal:  Lung Cancer       Date:  2003-01       Impact factor: 5.705

7.  Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis.

Authors:  Sunhwa Kim; Hiroyuki Takahashi; Wan-Wan Lin; Pascal Descargues; Sergei Grivennikov; Youngjun Kim; Jun-Li Luo; Michael Karin
Journal:  Nature       Date:  2009-01-01       Impact factor: 49.962

8.  Th22 cells are associated with hepatocellular carcinoma development and progression.

Authors:  Shanyu Qin; Shijia Ma; Xiaoli Huang; Donghong Lu; You Zhou; Haixing Jiang
Journal:  Chin J Cancer Res       Date:  2014-04       Impact factor: 5.087

9.  TLR7 promotes tumor progression, chemotherapy resistance, and poor clinical outcomes in non-small cell lung cancer.

Authors:  Saradiya Chatterjee; Lucile Crozet; Diane Damotte; Kristina Iribarren; Catherine Schramm; Marco Alifano; Audrey Lupo; Julien Cherfils-Vicini; Jeremy Goc; Sandrine Katsahian; Mohammad Younes; Marie Caroline Dieu-Nosjean; Wolf Herman Fridman; Catherine Sautès-Fridman; Isabelle Cremer
Journal:  Cancer Res       Date:  2014-07-29       Impact factor: 12.701

Review 10.  Tumor-associated macrophages contribute to tumor progression in ovarian cancer.

Authors:  Emily K Colvin
Journal:  Front Oncol       Date:  2014-06-06       Impact factor: 6.244

View more
  6 in total

1.  Genetic variant of IRAK2 in the toll-like receptor signaling pathway and survival of non-small cell lung cancer.

Authors:  Yinghui Xu; Hongliang Liu; Shun Liu; Yanru Wang; Jichun Xie; Thomas E Stinchcombe; Li Su; Ruyang Zhang; David C Christiani; Wei Li; Qingyi Wei
Journal:  Int J Cancer       Date:  2018-09-21       Impact factor: 7.396

2.  Krüppel like factor 6 splice variant 1 (KLF6-SV1) overexpression recruits macrophages to participate in lung cancer metastasis by up-regulating TWIST1.

Authors:  Jian Wang; Xiao Wang; Yawei Wang; Shuguang Li; Xiuwen Wang
Journal:  Cancer Biol Ther       Date:  2018-12-27       Impact factor: 4.742

3.  In silico identification of potential key regulatory factors in smoking-induced lung cancer.

Authors:  Salem A El-Aarag; Amal Mahmoud; Medhat H Hashem; Hatem Abd Elkader; Alaa E Hemeida; Mahmoud ElHefnawi
Journal:  BMC Med Genomics       Date:  2017-06-07       Impact factor: 3.063

4.  M2 polarization of macrophages facilitates arsenic-induced cell transformation of lung epithelial cells.

Authors:  Jiajun Cui; Wenhua Xu; Jian Chen; Hui Li; Lu Dai; Jacqueline A Frank; Shaojun Peng; Siying Wang; Gang Chen
Journal:  Oncotarget       Date:  2017-03-28

5.  A New Lectin from Auricularia auricula Inhibited the Proliferation of Lung Cancer Cells and Improved Pulmonary Flora.

Authors:  ZhenDong Liu; Liang Li; Bei Xue; DanDan Zhao; YanLong Zhang; XiuFeng Yan
Journal:  Biomed Res Int       Date:  2021-07-10       Impact factor: 3.411

6.  Novel sequence variants in the TLR6 gene associated with advanced breast cancer risk in the Saudi Arabian population.

Authors:  Abdelhabib Semlali; Mikhlid Almutairi; Mahmoud Rouabhia; Narasimha Reddy Parine; Abdullah Al Amri; Nouf S Al-Numair; Yousef M Hawsawi; Mohammad Saud Alanazi
Journal:  PLoS One       Date:  2018-11-02       Impact factor: 3.752

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.